Free Trial

Nephros (NEPH) SEC Filings & 10K Form

Nephros logo
$4.01 +0.21 (+5.53%)
As of 04:00 PM Eastern

Recent Nephros SEC Filings

DateFilerForm TypeView
04/30/2025
3:15 PM
Nephros (Filer)
Form DEF 14A
04/30/2025
3:16 PM
Nephros (Filer)
Form DEFA14A
04/30/2025
3:17 PM
Nephros (Filer)
Form ARS
04/28/2025
3:15 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
8:24 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
10:13 AM
Nephros (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/03/2025
5:13 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:03 PM
Nephros (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:15 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:18 PM
Nephros (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NEPH) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners